These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5531310)

  • 1. Thrombosis prevention by acetylsalicylic acid in hyperlipemic rats.
    Renaud S; Godu J
    Can Med Assoc J; 1970 Nov; 103(10):1037-40. PubMed ID: 5531310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between platelet aggregation and the thrombotic tendency in rats fed hyperlipemic diets.
    Renaud S; Kinlough RL; Mustard JF
    Lab Invest; 1970 Apr; 22(4):339-43. PubMed ID: 5429534
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombosis prevention by coagulation and platelet aggregtion inhibitors, in hyperlipemic rats.
    Renaud S; Lecompte F
    Thromb Diath Haemorrh; 1970 Dec; 24(3):577-86. PubMed ID: 5503948
    [No Abstract]   [Full Text] [Related]  

  • 4. Functional evaluation of platelet aspirin resistance after on-pump coronary bypass grafting using multiple aggregation tests.
    Kammerer I; Bach J; Saggau W; Isgro F
    Thorac Cardiovasc Surg; 2011 Oct; 59(7):425-9. PubMed ID: 21437867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meseclazone, 5-chlorosalicylic acid and acetylsalicylic acid. Comparison of their effects on in vitro and ex vivo platelet aggregation.
    Diamantis W; Kohlhepp WC; Haertlein B; Melton J; Sofia RD
    Thromb Haemost; 1978 Aug; 40(1):24-36. PubMed ID: 103240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of thrombosis using aspirin? nfluence of acetylsalicylic acid on thrombocyte aggregation in vitro and in vivo].
    Scharrer I; Schepping M; Breddin K
    Klin Wochenschr; 1969 Dec; 47(24):1318-24. PubMed ID: 5382021
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
    Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T
    Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Rivaroxaban on Platelet Activation and Platelet-Coagulation Pathway Interaction: In Vitro and In Vivo Studies.
    Perzborn E; Heitmeier S; Laux V
    J Cardiovasc Pharmacol Ther; 2015 Nov; 20(6):554-62. PubMed ID: 25848131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of acetylsalicylic acid on platelet aggregation and capillary bleeding in healthy cats].
    Hart S; Deniz A; Sommer B; Kietzmann M; Nolte I
    Dtsch Tierarztl Wochenschr; 1995 Dec; 102(12):476-80. PubMed ID: 8591748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet adherence to collagen. The influence of acetylsalicylic acid.
    Mant MJ
    Haemostasis; 1982; 12(3):262-7. PubMed ID: 7141304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of the combination of aspirin and nifedipine on platelet aggregation and thrombogenesis].
    Dong E; Shi S
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Oct; 18(5):301-3, 319. PubMed ID: 2086198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of large thrombi in hyperlipemic rats by epinephrine and endotoxin.
    Renaud S; Godu J
    Lab Invest; 1969 Dec; 21(6):512-8. PubMed ID: 5356787
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of intravenously administered acetylsalicylic acid on platelet functions. A pharmacodynamic and pharmacokinetic study.
    Vinazzer H; Pütter J; Loew D
    Haemostasis; 1975; 4(1):12-22. PubMed ID: 1193452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic effects of ximelagatran plus acetylsalicylic acid (ASA) and clopidogrel plus ASA in a human ex vivo arterial thrombosis model.
    Wåhlander K; Eriksson-Lepkowska M; Nyström P; Eriksson UG; Sarich TC; Badimon JJ; Kalies I; Elg M; Bylock A
    Thromb Haemost; 2006 Mar; 95(3):447-53. PubMed ID: 16525572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions.
    Hosokawa K; Ohnishi T; Sameshima H; Miura N; Ito T; Koide T; Maruyama I
    Thromb Haemost; 2013 Jan; 109(1):102-11. PubMed ID: 23179055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
    Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
    Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of tetrandrine on platelet aggregation, platelet adhesion and coagulation].
    Wu S; Zhao Z; Qi H
    Zhongguo Zhong Yao Za Zhi; 1990 Apr; 15(4):233-5, 255-6. PubMed ID: 2206376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
    Vilahur G; Segalés E; Salas E; Badimon L
    Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.